RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 106 filers reported holding RAPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,947,691 | -8.0% | 297,695 | +3.5% | 0.00% | 0.0% |
Q2 2023 | $5,377,242 | +2.3% | 287,553 | +0.3% | 0.00% | 0.0% |
Q1 2023 | $5,258,633 | +5.7% | 286,574 | +14.1% | 0.00% | 0.0% |
Q4 2022 | $4,973,582 | -16.8% | 251,191 | +1.1% | 0.00% | 0.0% |
Q3 2022 | $5,979,000 | +33.5% | 248,496 | +1.2% | 0.00% | 0.0% |
Q2 2022 | $4,480,000 | -3.9% | 245,471 | +15.8% | 0.00% | 0.0% |
Q1 2022 | $4,662,000 | -40.9% | 212,029 | -1.2% | 0.00% | 0.0% |
Q4 2021 | $7,885,000 | +16.9% | 214,696 | -1.2% | 0.00% | 0.0% |
Q3 2021 | $6,745,000 | +14.2% | 217,198 | +17.0% | 0.00% | 0.0% |
Q2 2021 | $5,904,000 | +95.0% | 185,693 | +36.1% | 0.00% | 0.0% |
Q1 2021 | $3,028,000 | +1.7% | 136,423 | -9.5% | 0.00% | 0.0% |
Q4 2020 | $2,978,000 | -37.7% | 150,793 | +1.6% | 0.00% | 0.0% |
Q3 2020 | $4,780,000 | +10.5% | 148,445 | -0.4% | 0.00% | 0.0% |
Q2 2020 | $4,326,000 | +513.6% | 149,073 | +350.2% | 0.00% | – |
Q1 2020 | $705,000 | +72.0% | 33,110 | +122.8% | 0.00% | – |
Q4 2019 | $410,000 | – | 14,859 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |